A systematic review on the efficacy and safety of low molecular weight heparin as an anticancer therapeutic in preclinical animal models

The therapeutic effects of low molecular weight heparins (LMWH) may extend past thrombosis prevention, with preclinical evidence demonstrating anti-metastatic properties. Clinical evidence on the topic, however, remains controversial. A systematic review of preclinical evidence may help elucidate re...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Thrombosis research 2020-11, Vol.195, p.103-113
Hauptverfasser: Ripsman, David, Fergusson, Dean A., Montroy, Joshua, Auer, Rebecca C., Huang, Johnny W., Dobriyal, Aditi, Wesch, Neil, Carrier, Marc, Lalu, Manoj M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!